Cathie Wood's ARK Innovation Stocks Performance Guide: Crispr Therapeutics (CRSP)
CRSP has no dividends.
Table and Chart of CRSP Performance
See what a $1,000 investment in CRSP is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CRSP Returns | |
|---|---|
| Start Date | Nov-30-2016 |
| Start Price | $21.82 |
| End Date | May-17-2024 |
| End Price | $56.22 |
| # Prices | 91 |
| Min Date | May-31-2017 |
| Min Price | $13.62 |
| Max Date | Jan-29-2021 |
| Max Price | $165.70 |
| Total Return | 157.65% |
| Annualized Return | 13.29% |
| Current Value of $1,000 Purchase | $2,577 |
| Number Returns | 4,095 |
| Average Return | 89.51% |
| Number Profitable Returns | 2,842 |
| Percent Profitable Returns | 69.40% |
| Number Unprofitable Returns | 1,253 |
| Percent Unprofitable Returns | 30.60% |
| Profitable to Unprofitable Returns Ratio | 2.27 |
| CRSP Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $4,727,390,000 |
| Beta | 1.792 | Price to Sales | 13.87 |
| Earnings per Share | $-2.7000 |
| PE Ratio | None |
| PE to Growth Ratio | -0.214 |
| Price to Book | 2.735 |
| PRICE DATA | |
| 52 Week High | $91.1 |
| 52 Week Low | $37.55 |
| Analyst Target Price | $84.5 |
| 50-Day Moving Average | $62.79 |
| 200-Day Moving Average | $59.31 |
| FINANCIAL DATA | |
| Revenue per Share | $3.396 |
| Revenue | $271,710,000 |
| Profit Margin | -79.9% |
| Return on Equity | -11% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CRSP Compare Returns with S&P 500
CRSP Trendline Chart
CRSP Moving Average Chart
CRSP Stock Return Map - See Patterns of Gains and Losses
CRSP Stock Returns/Purchase Dates